
Viatris Inc. (VTRS), headquartered in Canonsburg, Pennsylvania, is a global healthcare company that supplies high-quality medicines to approximately 1 billion patients worldwide annually. Valued at $12.54 billion by market cap, the company offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (API).
Shares of this healthcare company have underperformed the broader market considerably over the past year. VTRS has gained 14% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 27.1%. In 2024, shares of VTRS are down 2.8%, while the SPX is up 10.4% on a YTD basis.